Literature DB >> 9500552

Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.

T A Prolla1, S M Baker, A C Harris, J L Tsao, X Yao, C E Bronner, B Zheng, M Gordon, J Reneker, N Arnheim, D Shibata, A Bradley, R M Liskay.   

Abstract

Germline mutations in the human MSH2, MLH1, PMS2 and PMS1 DNA mismatch repair (MMR) gene homologues appear to be responsible for most cases of hereditary non-polyposis colorectal cancer (HNPCC; refs 1-5). An important role for DNA replication errors in colorectal tumorigenesis has been suggested by the finding of frequent alterations in the length of specific mononucleotide tracts within genes controlling cell growth, including TGF-beta receptor type II (ref. 6), BAX (ref. 7) and APC (ref. 8). A broader role for MMR deficiency in human tumorigenesis is implicated by microsatellite instability in a fraction of sporadic tumours, including gastric, endometrial and colorectal malignancies. To better define the role of individual MMR genes in cancer susceptibility and MMR functions, we have generated mice deficient for the murine homologues of the human genes MLH1, PMS1 and PMS2. Surprisingly, we find that these mice show different tumour susceptibilities, most notably, to intestinal adenomas and adenocarcinomas, and different mutational spectra. Our results suggest that a general increase in replication errors may not be sufficient for intestinal tumour formation and that these genes share overlapping, but not identical functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500552     DOI: 10.1038/ng0398-276

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  106 in total

1.  Multiple functions of MutS- and MutL-related heterocomplexes.

Authors:  T Nakagawa; A Datta; R D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Most retroviral recombinations occur during minus-strand DNA synthesis.

Authors:  J Zhang; L Y Tang; T Li; Y Ma; C M Sapp
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  The cellular mismatch repair system is able to repair mismatches within MLV retroviral double-stranded DNA at a low frequency.

Authors:  L Y Tang; J Zhang
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

4.  hMutSalpha forms an ATP-dependent complex with hMutLalpha and hMutLbeta on DNA.

Authors:  Guido Plotz; Jochen Raedle; Angela Brieger; Jörg Trojan; Stefan Zeuzem
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

5.  Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin.

Authors:  Hideki Shimodaira; Atsuko Yoshioka-Yamashita; Richard D Kolodner; Jean Y J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

6.  Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer.

Authors:  A Loukola; S Vilkki; J Singh; V Launonen; L A Aaltonen
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

7.  A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation.

Authors:  Xiaoping Wu; Connie Y Tsai; Marienida B Patam; Hong Zan; Jessica P Chen; Steve M Lipkin; Paolo Casali
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

8.  Genetic and Chemical Models of Colorectal Cancer in Mice.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2010-03-10

Review 9.  Mouse models of inherited cancer syndromes.

Authors:  Sohail Jahid; Steven Lipkin
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

10.  Alternative induction of meiotic recombination from single-base lesions of DNA deaminases.

Authors:  Siim Pauklin; Julia S Burkert; Julie Martin; Fekret Osman; Sandra Weller; Simon J Boulton; Matthew C Whitby; Svend K Petersen-Mahrt
Journal:  Genetics       Date:  2009-02-23       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.